| | Call Details | Conceptus Earnings Conference Call (Q1 2008) Tue,
May 6, 2008, 4:30 pm Eastern
| | About Conceptus
(NasdaqGM:CPTS) |
| | Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications. The company offers Essure, a permanent birth control system for women, which provides a non-incisional alternative to tubal ligation. The Essure system uses a micro-insert that is delivered into a woman's fallopian tubes to provide permanent birth control by causing a benign tissue in-growth that blocks the fallopian tubes. It sells its products through direct sales force in the United States and through distributor network internationally. The company was founded in 1992 and is headquartered in Mountain View, California. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|